Trial Profile
ASP1585 Pharmacokinetic Interaction Study - Pharmacokinetic Interaction With Atorvastatin.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Bixalomer (Primary) ; Atorvastatin
- Indications Alzheimer's disease; Atrial fibrillation; Cardiovascular disorders; Diabetic foot ulcer; Heart failure; Hypercholesterolaemia; Hyperlipoproteinaemia type II; Hyperlipoproteinaemia type III; Hyperphosphataemia; Hypertriglyceridaemia; Neurological disorders; Retinal vascular occlusion; Systemic lupus erythematosus
- Focus Pharmacokinetics
- 26 May 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 26 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 May 2010 New trial record